VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113
Last updated 2015-02-03
Summary
Prospective studies on the incidence of VTE during severe sepsis and septic shock remain absent, hindering efficacy assessments regarding current VTE prevention strategies in septic patients. The investigators will prospectively study consecutively enrolled ICU patients with severe sepsis and septic shock admitted at three hospitals. All patients will provide informed consent and the study will be IRB approved. VTE thromboprophylaxis, provided per standard of care and according to the patients' primary team, will be recorded for all patients. Patients will undergo bilateral lower (and upper, if a central venous catheter \[CVC\] was present) comprehensive compression ultrasonography (CUS) and will be followed for symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) prior to discharge. The investigators will perform multivariate regression analyses to identify predictors of VTE.
Conditions
- Severe Sepsis With Septic Shock
Interventions
- PROCEDURE
-
Ultrasound
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH - lead OTHER
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2014-12-31
More Related Trials
-
The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock
NCT02566460 ·Status: COMPLETED ·Phase: NA
-
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
NCT06010186 ·Status: RECRUITING ·Phase: NA
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Therapeutic Plasma Exchange in Septic Shock: A Pilot Study
NCT05093075 ·Status: RECRUITING ·Phase: PHASE2
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
NCT01867905 ·Status: COMPLETED
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
Comparison of ECMO Use and Conventional Treatment in Adults With Septic Shock
NCT01685112 ·Status: UNKNOWN
-
Ultrasound Optimization of Initial Fluid Challenge in Sepsis
NCT04028102 ·Status: UNKNOWN
-
A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of Outcome
NCT01775956 ·Status: UNKNOWN
-
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
NCT04948372 ·Status: COMPLETED ·Phase: NA
-
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 ·Status: WITHDRAWN
-
Resuscitation Strategies in Septic Shock
NCT02150512 ·Status: UNKNOWN ·Phase: NA
-
Strain Echocardiography During Septic Shock : an Observational Pilot Study
NCT03663192 ·Status: COMPLETED
-
Role of Thromboelastography in Septic Shock
NCT03095625 ·Status: COMPLETED
-
Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis
NCT04057872 ·Status: COMPLETED ·Phase: PHASE1
-
Microcirculatory Oxygen Uptake in Sepsis
NCT02430142 ·Status: COMPLETED
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock
NCT03014063 ·Status: COMPLETED
-
Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients
NCT06958809 ·Status: NOT_YET_RECRUITING
-
Change in MAPSE During Treatment of Sepsis
NCT05634733 ·Status: RECRUITING
-
Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock
NCT06990295 ·Status: RECRUITING ·Phase: NA
-
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis
NCT05787184 ·Status: UNKNOWN
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Severe Septic Shock Complications
NCT03716895 ·Status: UNKNOWN
-
Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock
NCT01150409 ·Status: TERMINATED ·Phase: PHASE4